|
1
|
Perrone A, Giovino A, Benny J and
Martinelli F: Advanced glycation end products (AGEs): Biochemistry,
signaling, analytical methods, and epigenetic effects. Oxid Med
Cell Longev. 2020:38181962020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Twarda-Clapa A, Olczak A, Białkowska AM
and Koziołkiewicz M: Advanced glycation end-products (AGEs):
Formation, chemistry, classification, receptors, and diseases
related to AGEs. Cells. 11:13122022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuzan A: Toxicity of advanced glycation
end products (Review). Biomed Rep. 14:462021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aaseth J, Skalny AV, Roos PM, Alexander J,
Aschner M and Tinkov AA: Copper, iron, selenium and lipo-glycemic
dysmetabolism in Alzheimer's disease. Int J Mol Sci. 22:94612021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luevano-Contreras C, Garay-Sevilla ME and
Chapman-Novakofski K: Role of dietary advanced glycation end
products in diabetes mellitus. J Evid Based Complementary Altern
Med. 18:50–66. 2013. View Article : Google Scholar
|
|
6
|
Song Q, Liu J, Dong L, Wang X and Zhang X:
Novel advances in inhibiting advanced glycation end product
formation using natural compounds. Biomed Pharmacother.
140:1117502021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vlassara H and Uribarri J: Advanced
glycation end products (AGE) and diabetes: Cause, effect, or both?
Curr Diab Rep. 14:4532014. View Article : Google Scholar :
|
|
8
|
Uribarri J, del Castillo MD, de la Maza
MP, Filip R, Gugliucci A, Luevano-Contreras C, Macías-Cervantes MH,
Markowicz Bastos DH, Medrano A, Menini T, et al: Dietary advanced
glycation end products and their role in health and disease. Adv
Nutr. 6:461–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sruthi CR and Raghu KG: Advanced glycation
end products and their adverse effects: The role of autophagy. J
Biochem Mol Toxicol. 35:e227102021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruiz HH, Ramasamy R and Schmidt AM:
Advanced glycation end products: Building on the concept of the
'common soil' in metabolic disease. Endocrinology. 161:bqz0062020.
View Article : Google Scholar
|
|
11
|
Margina D, Gradinaru D, Manda G, Neagoe I
and Ilie M: Membranar effects exerted in vitro by
polyphenols-quercetin, epigallocatechin gallate and curcumin-on
HUVEC and Jurkat cells, relevant for diabetes mellitus. Food Chem
Toxicol. 61:86–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chrysanthou M, Miro Estruch I, Rietjens
IMCM, Wichers HJ and Hoppenbrouwers T: In vitro methodologies to
study the role of advanced glycation end products (AGEs) in
neurodegeneration. Nutrients. 14:3632022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khan H, Khan MS and Ahmad S: The in vivo
and in vitro approaches for establishing a link between advanced
glycation end products and lung cancer. J Cell Biochem.
119:9099–9109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ge W, Jie J, Yao J, Li W, Cheng Y and Lu
W: Advanced glycation end products promote osteoporosis by inducing
ferroptosis in osteoblasts. Mol Med Rep. 25:1402022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu JL, Cai YQ, Long SL, Chen Z and Mo ZC:
The role of advanced glycation end products in human infertility.
Life Sci. 255:1178302020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bettiga A, Fiorio F, Di Marco F, Trevisani
F, Romani A, Porrini E, Salonia A, Montorsi F and Vago R: The
modern western diet rich in advanced glycation end-products (AGEs):
An overview of its impact on obesity and early progression of renal
pathology. Nutrients. 11:17482019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moskalev A, Stambler I and Caruso C:
Innate and adaptive immunity in aging and longevity: The foundation
of resilience. Aging Dis. 11:1363–1373. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Borsa C, Gradinaru D, Margina D, Prada G
and Peña C: Receptor of advanced glycation end products and
cardiovascular risk in elderly with type 2 diabetes mellitus. J
Biol Res. 90:81–86. 2017.
|
|
19
|
Sharifi-Zahabi E, Sharafabad FH,
Abdollahzad H, Malekahmadi M and Rad NB: Circulating advanced
glycation end products and their soluble receptors in relation to
all-cause and cardiovascular mortality: A systematic review and
meta-analysis of prospective observational studies. Adv Nutr.
12:2157–2171. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nowotny K, Schröter D, Schreiner M and
Grune T: Dietary advanced glycation end products and their
relevance for human health. Ageing Res Rev. 47:55–66. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inan-Eroglu E, Ayaz A and Buyuktuncer Z:
Formation of advanced glycation endproducts in foods during cooking
process and underlying mechanisms: A comprehensive review of
experimental studies. Nutr Res Rev. 33:77–89. 2020. View Article : Google Scholar
|
|
22
|
Gill V, Kumar V, Singh K, Kumar A and Kim
JJ: Advanced glycation end products (AGEs) may be a striking link
between modern diet and health. Biomolecules. 9:8882019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin JA, Wu CH and Yen GC: Perspective of
advanced glycation end products on human health. J Agric Food Chem.
66:2065–2070. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Dongen KCW, Kappetein L, Miro Estruch
I, Belzer C, Beekmann K and Rietjens IMCM: Differences in kinetics
and dynamics of endogenous versus exogenous advanced glycation end
products (AGEs) and their precursors. Food Chem Toxicol.
164:1129872022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Srebreva LN, Stoynev GA and Ivanov IG:
Evidence for excretion of glycation agents from E. coli cells
during growth. Biotechnol Biotechnol Equip. 23:1068–1071. 2009.
View Article : Google Scholar
|
|
26
|
Baskaran S, Rajan DP and Balasubramanian
KA: Formation of methylglyoxal by bacteria isolated from human
faeces. J Med Microbiol. 28:211–215. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao C, Dong H, Zhang Y and Li Y:
Discovery of potential genes contributing to the biosynthesis of
short-chain fatty acids and lactate in gut microbiota from
systematic investigation in E. coli. NPJ Biofilms Microbiomes.
5:192019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Popkov VA, Zharikova AA, Demchenko EA,
Andrianova NV, Zorov DB and Plotnikov EY: Gut microbiota as a
source of uremic toxins. Int J Mol Sci. 23:4832022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chakraborty S, Karmakar K and Chakravortty
D: Cells producing their own nemesis: Understanding methylglyoxal
metabolism. IUBMB Life. 66:667–678. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee C and Park C: Bacterial responses to
glyoxal and methylglyoxal: reactive electrophilic species. Int J
Mol Sci. 18:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rabie E, Serem JC, Oberholzer HM, Gaspar
AR and Bester MJ: How methylglyoxal kills bacteria: An
ultrastructural study. Ultrastruct Pathol. 40:107–111. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Booth IR, Ferguson GP, Miller S, Li C,
Gunasekera B and Kinghorn S: Bacterial production of methylglyoxal:
A survival strategy or death by misadventure? Biochem Soc Trans.
31:1406–1408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ferguson GP, Tötemeyer S, MacLean MJ and
Booth IR: Methylglyoxal production in bacteria: Suicide or
survival? Arch Microbiol. 170:209–218. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hellwig M, Bunzel D, Huch M, Franz CMAP,
Kulling SE and Henle T: Stability of individual maillard reaction
products in the presence of the human colonic microbiota. J Agric
Food Chem. 63:6723–6730. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bui TPN, Troise AD, Fogliano V and de Vos
WM: Anaerobic degradation of N-ε-carboxymethyllysine, a major
glycation end-product, by human intestinal bacteria. J Agric Food
Chem. 67:6594–6602. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bui TPN, Troise AD, Nijsse B, Roviello GN,
Fogliano V and de Vos WM: Intestinimonas-like bacteria are
important butyrate producers that utilize Nε-fructosyllysine and
lysine in formula-fed infants and adults. J Funct Foods.
70:1039742020. View Article : Google Scholar
|
|
37
|
Hellwig M, Auerbach C, Müller N, Samuel P,
Kammann S, Beer F, Gunzer F and Henle T: Metabolization of the
advanced glycation end product N-ε-carboxymethyllysine (CML) by
different probiotic E. coli Strains. J Agric Food Chem.
67:1963–1972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brunt VE, Casso AG, Gioscia-Ryan RA,
Sapinsley ZJ, Ziemba BP, Clayton ZS, Bazzoni AE, VanDongen NS,
Richey JJ, Hutton DA, et al: Gut microbiome-derived metabolite
trimethylamine N-oxide induces aortic stiffening and increases
systolic blood pressure with aging in mice and humans.
Hypertension. 78:499–511. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Taguchi K, Fukami K, Elias BC and Brooks
CR: Dysbiosis-related advanced glycation endproducts and
trimethylamine N-oxide in chronic kidney disease. Toxins (Basel).
13:3612021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Scott KP, Gratz SW, Sheridan PO, Flint HJ
and Duncan SH: The influence of diet on the gut microbiota.
Pharmacol Res. 69:52–60. 2013. View Article : Google Scholar
|
|
41
|
Wu S, Bhat ZF, Gounder RS, Mohamed Ahmed
IA, Al-Juhaimi FY, Ding Y and Bekhit AEA: Effect of dietary protein
and processing on gut microbiota-A systematic review. Nutrients.
14:4532022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mills DJS, Tuohy KM, Booth J, Buck M,
Crabbe MJC, Gibson GR and Ames JM: Dietary glycated protein
modulates the colonic microbiota towards a more detrimental
composition in ulcerative colitis patients and non-ulcerative
colitis subjects. J Appl Microbiol. 105:706–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Seiquer I, Rubio LA, Peinado MJ,
Delgado-Andrade C and Navarro MP: Maillard reaction products
modulate gut microbiota composition in adolescents. Mol Nutr Food
Res. 58:1552–1560. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qu W, Yuan X, Zhao J, Zhang Y, Hu J, Wang
J and Li J: Dietary advanced glycation end products modify gut
microbial composition and partially increase colon permeability in
rats. Mol Nutr Food Res. 61:2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qu W, Nie C, Zhao J, Ou X, Zhang Y, Yang
S, Bai X, Wang Y, Wang J and Li J: Microbiome-metabolomics analysis
of the impacts of long-term dietary advanced-glycation-end-product
consumption on C57BL/6 mouse fecal microbiota and metabo-lites. J
Agric Food Chem. 66:8864–8875. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van Dongen KCW, Linkens AMA, Wetzels SMW,
Wouters K, Vanmierlo T, van de Waarenburg MPH, Scheijen JLJM, de
Vos WM, Belzer C and Schalkwijk CG: Dietary advanced glycation
endproducts (AGEs) increase their concentration in plasma and
tissues, result in inflammation and modulate gut microbial
composition in mice; evidence for reversibility. Food Res Int.
147:1105472021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mastrocola R, Collotta D, Gaudioso G, Le
Berre M, Cento AS, Ferreira Alves G, Chiazza F, Verta R, Bertocchi
I, Manig F, et al: Effects of exogenous dietary advanced glycation
end products on the cross-talk mechanisms linking microbiota to
metabolic inflammation. Nutrients. 12:24972020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gaudioso G, Collotta D, Chiazza F,
Mastrocola R, Cento A, Fava F, Aragno M, Collino M and Tuohy K:
Advanced glycation end products (AGEs) in metabolic disease:
Linking diet, inflammation and microbiota. Proc Nutr Soc.
79:E3682020. View Article : Google Scholar
|
|
49
|
Han K, Yao Y, Dong S, Jin S, Xiao H, Wu H
and Zeng M: Chemical characterization of the glycated myofibrillar
proteins from grass carp (Ctenopharyngodon idella) and their
impacts on the human gut microbiota in vitro fermentation. Food
Funct. 8:1184–1194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Han K, Jin W, Mao Z, Dong S, Zhang Q, Yang
Y, Chen B, Wu H and Zeng M: Microbiome and butyrate production are
altered in the gut of rats fed a glycated fish protein diet. J
Funct Foods. 47:423–433. 2018. View Article : Google Scholar
|
|
51
|
Jin W, Han K, Dong S, Yang Y, Mao Z, Su M
and Zeng M: Modifications in gut microbiota and fermentation
metabolites in the hindgut of rats after the consumption of
galactooligosaccharide glycated with a fish peptide. Food Funct.
9:2853–2864. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang Y, Wu H, Dong S, Jin W, Han K, Ren Y
and Zeng M: Glycation of fish protein impacts its fermentation
metabolites and gut microbiota during in vitro human colonic
fermentation. Food Res Int. 113:189–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mao Z, Ren Y, Zhang Q, Dong S, Han K, Feng
G, Wu H and Zhao Y: Glycated fish protein supplementation modulated
gut microbiota composition and reduced inflammation but increased
accumulation of advanced glycation end products in high-fat diet
fed rats. Food Funct. 10:3439–3451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Corzo-Martínez M, Ávila M, Moreno FJ,
Requena T and Villamiel M: Effect of milk protein glycation and
gastrointestinal digestion on the growth of bifidobacteria and
lactic acid bacteria. Int J Food Microbiol. 153:420–427. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Corzo-Martínez M, Hernandez-Hernandez O,
Villamiel M, Rastall RA and Moreno FJ: In vitro bifidogenic effect
of Maillard-type milk protein-galactose conjugates on the human
intestinal microbiota. Int Dairy J. 31:127–131. 2013. View Article : Google Scholar
|
|
56
|
Shao YH, Zhang Y, Zhang L, Liu J and Tu
ZC: Mechanism of reduction in allergenicity and altered human
intestinal microbiota of digested β-lactoglobulin modified by
ultrasonic pretreatment combined with glycation. J Agric Food Chem.
69:14004–14012. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen Y, Guo KM, Nagy T and Guo TL: Chronic
oral exposure to glycated whey proteins increases survival of aged
male NOD mice with autoimmune prostatitis by regulating the gut
microbiome and anti-inflammatory responses. Food Funct. 11:153–162.
2020. View Article : Google Scholar :
|
|
58
|
Świątecka D, Narbad A, Ridgway KP and
Kostyra H: The study on the impact of glycated pea proteins on
human intestinal bacteria. Int J Food Microbiol. 145:267–272. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yacoub R, Nugent M, Cai W, Nadkarni GN,
Chaves LD, Abyad S, Honan AM, Thomas SA, Zheng W, Valiyaparambil
SA, et al: Advanced glycation end products dietary restriction
effects on bacterial gut microbiota in peritoneal dialysis
patients; a randomized open label controlled trial. PLoS One.
12:e01847892017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Linkens AMA, van Best N, Niessen PM,
Wijckmans NEG, de Goei EEC, Scheijen JLJM, van Dongen MCJM, van
Gool CCJAW, de Vos WM, Houben AJHM, et al: A 4-week diet low or
high in advanced glycation endproducts has limited impact on gut
microbial composition in abdominally obese individuals: The
deAGEing trial. Int J Mol Sci. 23:53282022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cao C, Tang M, Zhao N, Dong S and Wu H:
Effects of fish protein with glycation extent on gut microbiota and
colonic barrier function in mice fed a high-fat diet. J Funct
Foods. 85:1046362021. View Article : Google Scholar
|
|
62
|
Yuan X, Nie C, Liu H, Ma Q, Peng B, Zhang
M, Chen Z and Li J: Comparison of metabolic fate, target organs,
and microbiota interactions of free and bound dietary advanced
glycation end products. Crit Rev Food Sci Nutr. Oct 26–2021.Epub
ahead of print. View Article : Google Scholar
|
|
63
|
Zhao D, Sheng B, Wu Y, Li H, Xu D, Nian Y,
Mao S, Li C, Xu X and Zhou G: Comparison of free and bound advanced
glycation end products in food: A review on the possible influence
on human health. J Agric Food Chem. 67:14007–14018. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xu D, Li L, Zhang X, Yao H, Yang M, Gai Z,
Li B and Zhao D: Degradation of peptide-bound maillard reaction
products in gastrointestinal digests of glyoxal-glycated casein by
human colonic microbiota. J Agric Food Chem. 67:12094–12104. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gurung M, Li Z, You H, Rodrigues R, Jump
DB, Morgun A and Shulzhenko N: Role of gut microbiota in type 2
diabetes pathophysiology. EBioMedicine. 51:1025902020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wu Y, Zong M, Wu H, He D, Li L, Zhang X,
Zhao D and Li B: Dietary advanced glycation end-products affects
the progression of early diabetes by intervening in carbohydrate
and lipid metabolism. Mol Nutr Food Res. 66:e22000462022.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang J, Cai W, Yu J, Liu H, He S, Zhu L
and Xu J: Dietary advanced glycation end products shift the gut
microbiota composition and induce insulin resistance in mice.
Diabetes Metab Syndr Obes. 15:427–437. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Su L, Hong Z, Zhou T, Jian Y, Xu M, Zhang
X, Zhu X and Wang J: Health improvements of type 2 diabetic
patients through diet and diet plus fecal microbiota
transplantation. Sci Rep. 12:11522022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Murros KE, Huynh VA, Takala TM and Saris
PEJ: Desulfovibrio bacteria are associated with Parkinson's
disease. Front. Cell Infect Microbiol. 11:6526172021. View Article : Google Scholar
|
|
70
|
Chen YR, Jing QL, Chen FL, Zheng H, Chen
LD and Yang ZC: Desulfovibrio is not always associated with adverse
health effects in the guangdong gut microbiome project. PeerJ.
9:e120332021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Snelson M, Tan SM, Sourris K,
Thallas-Bonke V, Ziemann M, El-Osta S, Cooper M and Coughlan M:
SAT-301 resistant starch ameliorates advanced glycation
endproduct-induced gut dysbiosis and albuminuria in a mouse model
of type 2 diabetes. Kidney Int Rep. 4(Suppl): S1342019. View Article : Google Scholar
|
|
72
|
Reddy VP, Aryal P and Darkwah EK: Advanced
glycation end products in health and disease. Microorganisms.
10:18482022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Semba RD, Nicklett EJ and Ferrucci L: Does
accumulation of advanced glycation end products contribute to the
aging phenotype? J Gerontol A Biol Sci Med Sci. 65:963–975. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Maynard C and Weinkove D: The gut
microbiota and ageing. Subcell Biochem. 90:351–371. 2018.
View Article : Google Scholar
|
|
75
|
Mossad O, Batut B, Yilmaz B, Dokalis N,
Mezö C, Nent E, Nabavi LS, Mayer M, Maron FJM, Buescher JM, et al:
Gut microbiota drives age-related oxidative stress and
mitochondrial damage in microglia via the metabolite
N6-carboxymethyllysine. Nat Neurosci. 25:295–305. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Li Y, Ning L, Yin Y, Wang R, Zhang Z, Hao
L, Wang B, Zhao X, Yang X, Yin L, et al: Age-related shifts in gut
microbiota contribute to cognitive decline in aged rats. Aging
(Albany NY). 12:7801–7817. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Guilherme MDS, Nguyen VTT, Reinhardt C and
Endres K: Impact of gut microbiome manipulation in 5xFAD mice on
Alzheimer's disease-like pathology. Microorganisms. 9:8152021.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ohira H, Tsuruya A, Oikawa D, Nakagawa W,
Mamoto R, Hattori M, Waki T, Takahashi S, Fujioka Y and Nakayama T:
Alteration of oxidative-stress and related marker levels in mouse
colonic tissues and fecal microbiota structures with chronic
ethanol administration: Implications for the pathogenesis of
ethanol-related colorectal cancer. PLoS One. 16:e02465802021.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bonfili L, Cecarini V, Gogoi O, Berardi S,
Scarpona S, Angeletti M, Rossi G and Eleuteri AM: Gut microbiota
manipulation through probiotics oral administration restores
glucose homeostasis in a mouse model of Alzheimer's disease.
Neurobiol Aging. 87:35–43. 2020. View Article : Google Scholar
|
|
80
|
Mihailović M, Živković M, Jovanović JA,
Tolinački M, Sinadinović M, Rajić J, Uskoković A, Dinić S, Grdović
N, Golić N and Vidaković M: Oral administration of probiotic
Lactobacillus paraplantarum BGCG11 attenuates diabetes-induced
liver and kidney damage in rats. J Funct Foods. 38:427–437. 2017.
View Article : Google Scholar
|
|
81
|
Al-Enazi AMM, Virk P, Hindi A, Awad MA,
Elobeid M and Qindeel R: Protective effect of probiotic bacteria
and its nanoformulation against cadmium-induced oxidative stress in
male Wistar rat. J King Saud Univ Sci. 32:3045–3051. 2020.
View Article : Google Scholar
|
|
82
|
Park HY, Lee HB, Lee SY, Oh MJ, Ha SK, Do
E, Lee HHL, Hur J, Lee KW, Nam MH, et al: Lactococcus lactis KF140
reduces dietary absorption of Nε-(Carboxymethyl)lysine
in rats and humans via β-galactosidase activity. Front Nutr.
9:9162622022. View Article : Google Scholar
|
|
83
|
Farhangi MA, Dehghan P and Namazi N:
Prebiotic supple-mentation modulates advanced glycation
end-products (AGEs), soluble receptor for AGEs (sRAGE), and
cardiometabolic risk factors through improving metabolic
endotoxemia: A randomized-controlled clinical trial. Eur J Nutr.
59:3009–3021. 2020. View Article : Google Scholar
|
|
84
|
Li Y, Peng Y, Shen Y, Zhang Y, Liu L and
Yang X: Dietary polyphenols: Regulate the advanced glycation end
products-RAGE axis and the microbiota-gut-brain axis to prevent
neurodegenerative diseases. Crit Rev Food Sci Nutr. May
19–2022.Epub ahead of print.
|
|
85
|
Wu Y, Dong L, Song Y, Wu Y, Zhang Y and
Wang S: Preventive effects of polysaccharides from Physalis
alkekengi L. on dietary advanced glycation end product-induced
insulin resistance in mice associated with the modulation of gut
microbiota. Int J Biol Macromol. 204:204–214. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yang S, Zhou H, Wang G, Zhong XH, Shen QL,
Zhang XJ, Li RY, Chen LH, Zhang YH and Wan Z: Quercetin is
protective against short-term dietary advanced glycation end
products intake induced cognitive dysfunction in aged ICR mice. J
Food Biochem. 44:e131642020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yonei Y, Ikeda T, Ogawa H, Yagi N, Takabe
W, Ito M and Morii H: Anti-glycation and improvement microbiota by
Geranium dielsianum extract: Relation to health problems in
athletes. Glycative Stress Res. 6:31–38. 2019.
|
|
88
|
Di Lorenzo F, De Castro C, Silipo A and
Molinaro A: Lipopolysaccharide structures of Gram-negative
populations in the gut microbiota and effects on host interactions.
FEMS Microbiol Rev. 43:257–272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Mohr AE, Crawford M, Jasbi P, Fessler S
and Sweazea KL: Lipopolysaccharide and the gut microbiota:
Considering structural variation. FEBS Lett. 596:849–875. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Aki T, Funakoshi T, Noritake K, Unuma K
and Uemura K: Extracellular glucose is crucially involved in the
fate decision of LPS-stimulated RAW264.7 murine macrophage cells.
Sci Rep. 10:105812020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Dhananjayan K, Gunawardena D, Hearn N,
Sonntag T, Moran C, Gyengesi E, Srikanth V and Münch G: Activation
of macrophages and microglia by interferon-γ and lipopolysaccharide
increases methylglyoxal production: A new mechanism in the
development of vascular complications and cognitive decline in type
2 diabetes mellitus? J Alzheimers Dis. 59:467–479. 2017. View Article : Google Scholar
|
|
92
|
Ko YH, Tsai MS, Lee PH, Liang JT and Chang
KC: Methylprednisolone stiffens aortas in
lipopolysaccharide-induced chronic inflammation in rats. PLoS One.
8:e696362013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Shamsaldeen YA, Alsugoor MH, Lione LA and
Benham CD: Dysfunction in nitric oxide synthesis in streptozotocin
treated rat aorta and role of methylglyoxal. Eur J Pharmacol.
842:321–328. 2019. View Article : Google Scholar
|
|
94
|
Kitaura A, Nishinaka T, Hamasaki S,
Hatipoglu OF, Wake H, Nishibori M, Mori S, Nakao S and Takahashi H:
Advanced glycation end-products reduce lipopolysaccharide uptake by
macrophages. PLoS One. 16:e02459572021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Chiu HC, Fu MM, Yang TS, Fu E, Chiang CY,
Tu HP, Chin YT, Lin FG and Shih KC: Effect of high glucose,
Porphyromonas gingivalis lipopolysaccharide and advanced glycation
end-products on production of interleukin-6/-8 by gingival
fibroblasts. J Periodontal Res. 52:268–276. 2017. View Article : Google Scholar
|
|
96
|
Liu J, Zhao S, Tang J, Li Z, Zhong T, Liu
Y, Chen D, Zhao M, Li Y, Gong X, et al: Advanced glycation end
products and lipopolysaccharide synergistically stimulate
proinflammatory cytokine/chemokine production in endothelial cells
via activation of both mitogen-activated protein kinases and
nuclear factor-kappaB. FEBS J. 276:4598–4606. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yamamoto Y and Yamamoto H: Interaction of
receptor for advanced glycation end products with advanced
oxidation protein products induces podocyte injury. Kidney Int.
82:733–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Pinkas A, Cunha Martins A Jr and Aschner
M: C. elegans-an emerging model to study metal-induced RAGE-related
pathologies. Int J Environ Res Public Health. 15:14072018.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lawes M, Pinkas A, Frohlich BA, Iroegbu
JD, Ijomone OM and Aschner M: Metal-induced neurotoxicity in a
RAGE-expressing C. elegans model. Neurotoxicology. 80:71–75. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wang L, Wu J, Guo X, Huang X and Huang Q:
RAGE plays a role in LPS-induced NF-κB activation and endothelial
hyperpermeability. Sensors (Basel). 17:7222017. View Article : Google Scholar
|
|
101
|
Li Y, Wu R, Tian Y, Yu M, Tang Y, Cheng H
and Tian Z: RAGE/NF-κB signaling mediates lipopolysaccharide
induced acute lung injury in neonate rat model. Int J Clin Exp Med.
8:13371–13376. 2015.
|
|
102
|
Li Y, Wu R, Zhao S, Cheng H, Ji P, Yu M
and Tian Z: RAGE/NF-κB pathway mediates lipopolysaccharide-induced
inflammation in alveolar type I epithelial cells isolated from
neonate rats. Inflammation. 37:1623–1629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yamamoto Y, Harashima A, Saito H,
Tsuneyama K, Munesue S, Motoyoshi S, Han D, Watanabe T, Asano M,
Takasawa S, et al: Septic shock is associated with receptor for
advanced glycation end products ligation of LPS. J Immunol.
186:3248–3257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Watanabe M, Toyomura T, Tomiyama M, Wake
H, Liu K, Teshigawara K, Takahashi H, Nishibori M and Mori S:
Advanced glycation end products (AGEs) synergistically potentiated
the proinflammatory action of lipopolysaccharide (LPS) and high
mobility group box-1 (HMGB1) through their direct interactions. Mol
Biol Rep. 47:7153–7159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Huang J, Xiong T, Zhang Z, Tan Y and Guo
L: Inhibition of the receptor for advanced glycation inhibits
lipopolysaccharide-mediated high mobility group protein B1 and
Interleukin-6 synthesis in human gingival fibroblasts through the
NF-κB signaling pathway. Arch Oral Biol. 105:81–87. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Cho HI, Hong JM, Choi JW, Choi HS, Hwan
Kwak J, Lee DU, Kook Lee S and Lee SM: β-Caryophyllene alleviates
D-galactosamine and lipopolysaccharide-induced hepatic injury
through suppression of the TLR4 and RAGE signaling pathways. Eur J
Pharmacol. 764:613–621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Goel R, Bhat SA, Hanif K, Nath C and
Shukla R: Perindopril attenuates lipopolysaccharide-induced
amyloidogenesis and memory impairment by suppression of oxidative
stress and RAGE activation. ACS Chem Neurosci. 7:206–217. 2016.
View Article : Google Scholar
|
|
108
|
Liu L, Zhao Z, Lu L, Liu J, Sun J, Wu X
and Dong J: Icariin and icaritin ameliorated hippocampus
neuroinflammation via inhibiting HMGB1-related pro-inflammatory
signals in lipopolysaccharide-induced inflammation model in C57BL/6
J mice. Int Immunopharmacol. 68:95–105. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Aneja RK, Tsung A, Sjodin H, Gefter JV,
Delude RL, Billiar TR and Fink MP: Preconditioning with high
mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS)
tolerance. J Leukoc Biol. 84:1326–1334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhou XY, Zhang WJ, Huang QB and Guo XH:
Role of RAGE in lipopolysaccharide-induced cytoskeletal changes in
mouse pulmonary microvascular endothelial cells. Nan Fang Yi Ke Da
Xue Xue Bao. 35:6–11. 2015.In Chinese. PubMed/NCBI
|
|
111
|
Wang H, Wang T, Yuan Z, Cao Y, Zhou Y, He
J, Shen Y, Zeng N, Dai L, Wen F and Chen L: Role of receptor for
advanced glycation end products in regulating lung fluid balance in
lipopolysaccharide-induced acute lung injury and infection-related
acute respiratory distress syndrome. Shock. 50:472–482. 2018.
View Article : Google Scholar
|
|
112
|
Li J, Wang K, Huang B, Li R, Wang X, Zhang
H, Tang H and Chen X: The receptor for advanced glycation end
products mediates dysfunction of airway epithelial barrier in a
lipopolysaccharides-induced murine acute lung injury model. Int
Immunopharmacol. 93:1074192021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Shi J, Fu Y, Zhao XH and Lametsch R:
Glycation sites and bioactivity of lactose-glycated caseinate
hydrolysate in lipopolysaccharide-injured IEC-6 cells. J Dairy Sci.
104:1351–1363. 2021. View Article : Google Scholar
|
|
114
|
You L, Cui H, Zhao F, Sun H, Zhong H, Zhou
G and Chen X: Inhibition of HMGB1/RAGE axis suppressed the
lipopolysaccharide (LPS)-induced vicious transformation of cervical
epithelial cells. Bioengineered. 12:4995–5003. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wilkie T, Verma AK, Zhao H, Charan M,
Ahirwar DK, Kant S, Pancholi V, Mishra S and Ganju RK:
Lipopolysaccharide from the commensal microbiota of the breast
enhances cancer growth: Role of S100A7 and TLR4. Mol Oncol.
16:1508–1522. 2022. View Article : Google Scholar :
|
|
116
|
Ramsgaard L, Englert JM, Manni ML,
Milutinovic PS, Gefter J, Tobolewski J, Crum L, Coudriet GM,
Piganelli J, Zamora R, et al: Lack of the receptor for advanced
glycation end-products attenuates E. coli pneumonia in mice. PLoS
One. 6:e201322011. View Article : Google Scholar : PubMed/NCBI
|
